FIELD: chemistry.
SUBSTANCE: suggested method of preparing a compound that inhibits the activation of complement, where the said compound is Xaa1-Cys-Val-Xaa2-Gln-Asp-Xaa3-Gly-Xaa4-His-Arg-Cys-Xaa5 (SEQ ID NO:26).
EFFECT: given compounds show significantly higher activity in inhibiting complement activation in comparison with the currently available compounds.
22 cl, 6 tbl, 8 dwg, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| EFFICIENT COMPSTATIN ANALOGUES | 2006 |
|
RU2474586C2 |
| PROLONGED DELIVERY OF COMPSTATIN ANALOGUES FROM GELS | 2008 |
|
RU2505311C2 |
| CELL-REACTIVE COMPSTATIN ANALOGS, LONG-ACTING COMPSTATIN ANALOGS, OR TARGETED COMPSTATIN ANALOGS AND USES THEREOF | 2012 |
|
RU2653439C9 |
| DOSING SCHEMES AND CORRESPONDING COMPOSITIONS AND METHODS | 2018 |
|
RU2779495C2 |
| CELL-REACTIVE COMPOSTATIN ANALOGUES, LONG-ACTING COMPSTATIN ANALOGUES OR COMPUTED EFFECT ANALOGUES OF TARGETED ACTION AND RELATED COMPOSITIONS AND METHODS | 2013 |
|
RU2705215C2 |
| INJECTION SCHEMES | 2016 |
|
RU2770099C2 |
| PEPTIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE ACIDS OR SALTS, PHARMACEUTICAL COMPOSITION SHOWING ANTAGONISTIC ACTIVITY WITH RESPECT TO BOMBESINE, METHOD OF TREATMENT OF MAMMALIAN WITH CANCER | 1994 |
|
RU2114118C1 |
| COMPLEMENT ACTIVITY MODULATION | 2015 |
|
RU2778514C2 |
| MODULATION OF COMPLEMENT ACTIVITY | 2015 |
|
RU2670988C2 |
| ANTIBODIES AGAINST FACTOR D AND THEIR USE | 2018 |
|
RU2799044C2 |
